Botulax 100 Units

Kuvaus

Botulax 100 Units is a lyophilized powder containing 100 units of purified botulinum toxin type A complex produced by Hugel Inc., a leading Korean biopharmaceutical company. It is supplied in a single-use vial and reconstituted with preservative-free 0.9% sodium chloride solution before injection. Botulax works by inhibiting acetylcholine release at the neuromuscular junction, causing precise, reversible muscle relaxation or suppression of glandular secretion—making it a reliable option for both aesthetic and therapeutic neuromodulation.

In aesthetic medicine, Botulax 100 Units is widely used (and approved in many countries) for the temporary improvement of moderate to severe:

• Glabellar frown lines
• Lateral canthal lines (crow’s feet)
• Horizontal forehead lines
• Additional off-label aesthetic indications include bunny lines, perioral rhytids, chin dimpling, masseter reduction (jaw slimming), platysmal bands, gummy smile, and hyperhidrosis

Typical cosmetic doses range from 20–60 units per session (depending on areas treated and muscle strength), with onset visible in 3–7 days, peak effect at 10–14 days, and duration generally 3–6 months (comparable to other major botulinum toxins in head-to-head studies and user reports). The 100-unit vial provides excellent flexibility for full-face treatments, multiple patients, or combination protocols in busy clinics.

Therapeutically, Botulax is approved or used in various regions for:

• Blepharospasm
• Cervical dystonia (spasmodic torticollis)
• Upper and lower limb spasticity
• Chronic migraine (in some markets)
• Focal hyperhidrosis
• Hemifacial spasm

Therapeutic doses vary significantly (often 50–300+ units total), requiring expert anatomical placement and frequently electromyography guidance.

Administration & Handling

• Reconstitute with 2.5 mL (for 4 U/0.1 mL) or 1.0–4.0 mL of sterile, preservative-free saline depending on desired concentration
• Use within 24 hours when refrigerated (2–8°C)
• Inject via fine-gauge needles (30–33G) or cannulas in aesthetic applications

Safety & Side Effects

Common side effects are mild and transient: injection-site pain, swelling, bruising, headache, eyelid ptosis, dry eyes, or mild flu-like symptoms. Serious but rare risks include distant spread of toxin effects (dysphagia, respiratory distress), allergic reactions, or antibody-mediated resistance with repeated use (comparable to other toxins). Contraindications include hypersensitivity to botulinum toxin or human albumin, active infection at injection site, and certain neuromuscular disorders (myasthenia gravis, Lambert-Eaton syndrome, ALS).

As of 2026, Botulax 100 Units is approved in over 60 countries (including South Korea, Europe, Asia, Latin America, the Middle East, and others) and has gained strong global market share due to its high purity, consistent potency, competitive pricing, and favorable safety profile. It is not FDA-approved in the United States (where similar products include Botox, Dysport, Xeomin, and Jeuveau), but it is legally and widely used in many regions. Botulax must be administered only by qualified healthcare professionals (dermatologists, plastic surgeons, neurologists, etc.) trained in botulinum toxin injection techniques, with thorough patient assessment, informed consent, and follow-up. Always source genuine Botulax from authorized distributors to ensure authenticity, potency, and safety.